As the patent on MS Contin, a morphine pill for cancer patients, moved toward expiration in the late 1980s, its maker, Purdue Pharma, began development on OxyContin. Fast forward a few years and $35 billion later and the opioid medication topped the charts as the country’s number one selling painkiller. The company had a problem, […]
Posted in
Posted in
